Search

New vaccine resource and important reminders for providers this month: April 2021

Featured story:

Browse our new vaccine resource page 

Massachusetts will open the final phase of the vaccine rollout to the general public on April 19, 2021. If patients are hesitant to get the vaccine, we've created a dedicated COVID-19 vaccine page with a curated collection of resources for you and your patients: 

Key messages to share with patients from the CDC

In this issue:

  • Medications obtained through the medical benefit
  • New products
  • New vaccine resource page
  • New guidelines
  • Hospital inpatient utilization report
  • New, revised, and retired medical policy updates
  • New codes
  • CPT code updates
  • Drug code updates

Request authorization for new-to-market medications through Novologix

Most medications covered on the medical benefit require prior authorization through Novologix (NLX). This now includes new-to-market medications.

Out of network providers should request authorization through AllWays Health Partners.


New limited network products meet customer needs

AllWays has experienced unprecedented growth in the commercial market. In response, we're developing new products that meet our customer's needs for high-quality, cost-effective care. This includes launching new limited network products, two of which are in-market right now. 

You don't need to take any action. Your rates won't change, and we'll notify you when your practice is part of a limited network. 

Read about Allies and Select Network below. You can find info about all of our products on our product reference page.

Allies HMO & Allies Choice
Designed to make high-quality care more affordable and accessible. Members will receive care at a top community hospital and get support from health navigators who ensure quicker access to care.

Visit our Allies page for providers and download the factsheet.

Select HMO
Select HMO members have in-network access to our new Select HMO network. Members will have access to comprehensive benefits at a lower cost through this limited network of high-quality providers.

Visit our Select Network page for providers

How do I know if I am participating in a limited network product?

  • You will receive an alert regarding your participation in the network when you check a member’s eligibility in the AllWays Health Partners provider portal.
  • You can also confirm your participation in the limited networks by checking our online Provider Directory

What is the difference between Non-participating and Not contracted?
Non-participating means you are a contracted provider with AllWays Health Partners however you are not part of that particular limited network. Non contracted refers to a provider or group who is not contracted with AllWays Health Partners for any lines of business


New guidelines

As of March 1, 2021, AllWays Health Partners has published new guidelines to determine medical necessity for Radiofrequency Ablation to Treat Uterine Fibroids. The guidelines are called Radiofrequency Ablation to Treat Uterine Fibroids (Custom) – AWH. To access this criteria, providers should log in to AllWays Health Partners’ provider website at allwaysprovider.org and click the InterQual® Criteria Lookup link under the Resources Menu.


Hospital inpatient utilization report

To review the latest quarterly hospital inpatient utilization report, click on the Reports tab in the Provider Portal and select Clinical Reports. If you do not have access to the Provider Portal, you may register online at allwaysprovider.org.


New medical policy updates

AllWays Health Partners has developed a new policy for the FDA-approved CAR-T cell therapy Tecartus. Tecartus is a treatment for adult patients with relapsed or refractory mantle cell lymphoma. Please see the table below for a brief summary.

[1] Exceptions for non-FDA approved CD19 therapies will be reviewed on an individual case by case basis. A detailed medical review will be required.

One new medical policy, Intravenous Ketamine for Treatment-Resistant Depression, has been posted to allwayshealthpartners.org with an 4/1/2021 effective date.


Revised medical policy updates


Retired medical policy update

Effective 4/1/2021, the policy Home Prothrombin Time Monitoring Devices will be retired.

  • The codes associated with the policy no longer require prior authorization.
  • You will no longer find the policy on the AllWays Health Partners medical policy webpage
  • You will no longer find the customized policy in InterQual.

New Codes

Not Covered Experimental and Investigational:

Not Covered per Benefit:


Covered when Prior Authorized:

Covered with No Prior Authorization:

Covered with No Prior Authorization for My Care Family Members; Not covered for Commercial/ASO Plans:


CPT code updates

As a reminder to our network the following service is not covered E/I across all lines of business:

The following services previously covered with PA will not be reimbursable across all lines of business, please resubmit with CPT for Commercial and ASO plans only, My Care Family plans will be not reimbursable:

The following services previously covered with PA will be covered with no PA required:

The following service previously not covered across all lines of business is now reimbursable with associated CPT code:

The following service is now covered as newborn preventive screenings for Commercial and ASO plans:


Drug Code Updates

The following drug(s) previously considered not covered experimental/investigational are now covered under the medical benefit; prior authorization required:

The following drug(s) previously considered not covered experimental/investigational are now covered under the medical benefit; no prior authorization required:

The following drug(s) covered under the medical benefit; prior authorization required will be represented by the following HCPCS codes effective 04/01/2021:




Contact Information

We are here to help! Contact us today:

Provider Service:

Provider Portal

Provider Blog

Join the Network

Subscribe Here

Join our Provider Roundtable

Share your feedback with us and your colleagues

Learn more
roundtablead

Recent Posts